nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP2A6—Progesterone—uterine cancer	0.228	0.266	CbGbCtD
Chlorzoxazone—CYP1A1—Progesterone—uterine cancer	0.195	0.227	CbGbCtD
Chlorzoxazone—CYP1A2—Progesterone—uterine cancer	0.0872	0.101	CbGbCtD
Chlorzoxazone—CYP2D6—Progesterone—uterine cancer	0.0718	0.0835	CbGbCtD
Chlorzoxazone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.069	0.0802	CbGbCtD
Chlorzoxazone—CYP2E1—Etoposide—uterine cancer	0.0675	0.0784	CbGbCtD
Chlorzoxazone—CYP3A4—Progesterone—uterine cancer	0.0457	0.0531	CbGbCtD
Chlorzoxazone—CYP1A2—Etoposide—uterine cancer	0.039	0.0454	CbGbCtD
Chlorzoxazone—CYP2D6—Doxorubicin—uterine cancer	0.0219	0.0255	CbGbCtD
Chlorzoxazone—CYP3A4—Etoposide—uterine cancer	0.0204	0.0238	CbGbCtD
Chlorzoxazone—CYP3A4—Doxorubicin—uterine cancer	0.0139	0.0162	CbGbCtD
Chlorzoxazone—KCNMA1—artery—uterine cancer	0.00798	0.146	CbGeAlD
Chlorzoxazone—KCNMA1—exocrine gland—uterine cancer	0.00696	0.127	CbGeAlD
Chlorzoxazone—Digestion impaired—Progesterone—uterine cancer	0.00414	0.0799	CcSEcCtD
Chlorzoxazone—KCNMA1—myometrium—uterine cancer	0.00386	0.0707	CbGeAlD
Chlorzoxazone—Digestion impaired—Medroxyprogesterone Acetate—uterine cancer	0.00375	0.0724	CcSEcCtD
Chlorzoxazone—KCNMA1—epithelium—uterine cancer	0.00303	0.0555	CbGeAlD
Chlorzoxazone—KCNMA1—smooth muscle tissue—uterine cancer	0.00292	0.0534	CbGeAlD
Chlorzoxazone—KCNMA1—decidua—uterine cancer	0.00286	0.0524	CbGeAlD
Chlorzoxazone—KCNMA1—renal system—uterine cancer	0.00281	0.0514	CbGeAlD
Chlorzoxazone—KCNMA1—uterus—uterine cancer	0.0025	0.0458	CbGeAlD
Chlorzoxazone—Lightheadedness—Progesterone—uterine cancer	0.00248	0.0478	CcSEcCtD
Chlorzoxazone—KCNMA1—female reproductive system—uterine cancer	0.00225	0.0412	CbGeAlD
Chlorzoxazone—CYP2A6—vagina—uterine cancer	0.0017	0.0311	CbGeAlD
Chlorzoxazone—Drowsiness—Progesterone—uterine cancer	0.00155	0.0299	CcSEcCtD
Chlorzoxazone—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.0271	CcSEcCtD
Chlorzoxazone—KCNMA1—lymph node—uterine cancer	0.00131	0.0241	CbGeAlD
Chlorzoxazone—CYP1A1—epithelium—uterine cancer	0.00131	0.024	CbGeAlD
Chlorzoxazone—CYP1A1—uterine cervix—uterine cancer	0.0013	0.0238	CbGeAlD
Chlorzoxazone—CYP1A2—renal system—uterine cancer	0.00123	0.0226	CbGeAlD
Chlorzoxazone—CYP1A1—renal system—uterine cancer	0.00121	0.0223	CbGeAlD
Chlorzoxazone—CYP1A1—mammalian vulva—uterine cancer	0.00114	0.0208	CbGeAlD
Chlorzoxazone—Ill-defined disorder—Progesterone—uterine cancer	0.00112	0.0217	CcSEcCtD
Chlorzoxazone—CYP2E1—renal system—uterine cancer	0.00111	0.0203	CbGeAlD
Chlorzoxazone—Angioedema—Progesterone—uterine cancer	0.00111	0.0213	CcSEcCtD
Chlorzoxazone—Malaise—Progesterone—uterine cancer	0.00109	0.0211	CcSEcCtD
Chlorzoxazone—CYP1A1—uterus—uterine cancer	0.00108	0.0198	CbGeAlD
Chlorzoxazone—Discomfort—Progesterone—uterine cancer	0.00102	0.0197	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.0196	CcSEcCtD
Chlorzoxazone—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.001	0.0193	CcSEcCtD
Chlorzoxazone—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000989	0.0191	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Progesterone—uterine cancer	0.000987	0.0191	CcSEcCtD
Chlorzoxazone—CYP1A1—female reproductive system—uterine cancer	0.000973	0.0178	CbGeAlD
Chlorzoxazone—Petechiae—Epirubicin—uterine cancer	0.000965	0.0186	CcSEcCtD
Chlorzoxazone—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000922	0.0178	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000895	0.0173	CcSEcCtD
Chlorzoxazone—Petechiae—Doxorubicin—uterine cancer	0.000892	0.0172	CcSEcCtD
Chlorzoxazone—CYP3A4—renal system—uterine cancer	0.000891	0.0163	CbGeAlD
Chlorzoxazone—CYP2E1—female reproductive system—uterine cancer	0.000887	0.0163	CbGeAlD
Chlorzoxazone—CYP1A1—female gonad—uterine cancer	0.000885	0.0162	CbGeAlD
Chlorzoxazone—CYP1A1—vagina—uterine cancer	0.00088	0.0161	CbGeAlD
Chlorzoxazone—Somnolence—Progesterone—uterine cancer	0.000878	0.0169	CcSEcCtD
Chlorzoxazone—CYP2D6—renal system—uterine cancer	0.000877	0.0161	CbGeAlD
Chlorzoxazone—Dyspepsia—Progesterone—uterine cancer	0.000869	0.0168	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Progesterone—uterine cancer	0.000852	0.0165	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Progesterone—uterine cancer	0.000814	0.0157	CcSEcCtD
Chlorzoxazone—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000795	0.0154	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Dactinomycin—uterine cancer	0.000793	0.0153	CcSEcCtD
Chlorzoxazone—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000788	0.0152	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000772	0.0149	CcSEcCtD
Chlorzoxazone—Malaise—Dactinomycin—uterine cancer	0.000771	0.0149	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000737	0.0142	CcSEcCtD
Chlorzoxazone—Discomfort—Dactinomycin—uterine cancer	0.000719	0.0139	CcSEcCtD
Chlorzoxazone—Ecchymosis—Epirubicin—uterine cancer	0.000717	0.0139	CcSEcCtD
Chlorzoxazone—CYP3A4—female reproductive system—uterine cancer	0.000714	0.0131	CbGeAlD
Chlorzoxazone—CYP2D6—female reproductive system—uterine cancer	0.000703	0.0129	CbGeAlD
Chlorzoxazone—Ecchymosis—Doxorubicin—uterine cancer	0.000664	0.0128	CcSEcCtD
Chlorzoxazone—Dizziness—Progesterone—uterine cancer	0.000653	0.0126	CcSEcCtD
Chlorzoxazone—CYP2D6—female gonad—uterine cancer	0.000639	0.0117	CbGeAlD
Chlorzoxazone—Rash—Progesterone—uterine cancer	0.000623	0.012	CcSEcCtD
Chlorzoxazone—Dermatitis—Progesterone—uterine cancer	0.000622	0.012	CcSEcCtD
Chlorzoxazone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000592	0.0114	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000576	0.0111	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Dactinomycin—uterine cancer	0.000575	0.0111	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Etoposide—uterine cancer	0.000574	0.0111	CcSEcCtD
Chlorzoxazone—CYP1A1—lymph node—uterine cancer	0.000569	0.0104	CbGeAlD
Chlorzoxazone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000564	0.0109	CcSEcCtD
Chlorzoxazone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000564	0.0109	CcSEcCtD
Chlorzoxazone—Malaise—Etoposide—uterine cancer	0.000558	0.0108	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000533	0.0103	CcSEcCtD
Chlorzoxazone—Discomfort—Etoposide—uterine cancer	0.000521	0.0101	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Etoposide—uterine cancer	0.000505	0.00975	CcSEcCtD
Chlorzoxazone—Somnolence—Etoposide—uterine cancer	0.000449	0.00867	CcSEcCtD
Chlorzoxazone—Drowsiness—Epirubicin—uterine cancer	0.000444	0.00857	CcSEcCtD
Chlorzoxazone—Rash—Dactinomycin—uterine cancer	0.00044	0.0085	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000436	0.00842	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Etoposide—uterine cancer	0.000416	0.00804	CcSEcCtD
Chlorzoxazone—Drowsiness—Doxorubicin—uterine cancer	0.000411	0.00793	CcSEcCtD
Chlorzoxazone—Dizziness—Etoposide—uterine cancer	0.000334	0.00645	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Epirubicin—uterine cancer	0.000322	0.00622	CcSEcCtD
Chlorzoxazone—Rash—Etoposide—uterine cancer	0.000318	0.00615	CcSEcCtD
Chlorzoxazone—Dermatitis—Etoposide—uterine cancer	0.000318	0.00614	CcSEcCtD
Chlorzoxazone—Malaise—Epirubicin—uterine cancer	0.000313	0.00604	CcSEcCtD
Chlorzoxazone—CYP1A1—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000307	0.00915	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000306	0.00911	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—uterine cancer	0.000301	0.00899	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine cancer	0.000299	0.00892	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000298	0.00888	CbGpPWpGaD
Chlorzoxazone—Ill-defined disorder—Doxorubicin—uterine cancer	0.000298	0.00575	CcSEcCtD
Chlorzoxazone—CYP2E1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000294	0.00876	CbGpPWpGaD
Chlorzoxazone—Discomfort—Epirubicin—uterine cancer	0.000292	0.00563	CcSEcCtD
Chlorzoxazone—Malaise—Doxorubicin—uterine cancer	0.000289	0.00559	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Epirubicin—uterine cancer	0.000283	0.00547	CcSEcCtD
Chlorzoxazone—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000281	0.00837	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000277	0.00827	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000277	0.00826	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000274	0.00816	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Tryptophan metabolism—CYP19A1—uterine cancer	0.000271	0.00808	CbGpPWpGaD
Chlorzoxazone—Discomfort—Doxorubicin—uterine cancer	0.00027	0.00521	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Doxorubicin—uterine cancer	0.000262	0.00506	CcSEcCtD
Chlorzoxazone—CYP1A1—Tryptophan metabolism—CYP19A1—uterine cancer	0.000256	0.00762	CbGpPWpGaD
Chlorzoxazone—Somnolence—Epirubicin—uterine cancer	0.000252	0.00486	CcSEcCtD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.00025	0.00745	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.00025	0.00745	CbGpPWpGaD
Chlorzoxazone—Dyspepsia—Epirubicin—uterine cancer	0.000249	0.00481	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000244	0.00472	CcSEcCtD
Chlorzoxazone—CYP2E1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000241	0.0072	CbGpPWpGaD
Chlorzoxazone—Feeling abnormal—Epirubicin—uterine cancer	0.000233	0.00451	CcSEcCtD
Chlorzoxazone—Somnolence—Doxorubicin—uterine cancer	0.000233	0.0045	CcSEcCtD
Chlorzoxazone—Dyspepsia—Doxorubicin—uterine cancer	0.000231	0.00445	CcSEcCtD
Chlorzoxazone—CYP1A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000228	0.00679	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000227	0.00678	CbGpPWpGaD
Chlorzoxazone—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000226	0.00437	CcSEcCtD
Chlorzoxazone—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000225	0.0067	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000219	0.00653	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000216	0.00645	CbGpPWpGaD
Chlorzoxazone—Feeling abnormal—Doxorubicin—uterine cancer	0.000216	0.00417	CcSEcCtD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000214	0.00639	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000211	0.0063	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000211	0.0063	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—NFE2L2—uterine cancer	0.000209	0.00623	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000209	0.00622	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000207	0.00616	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000204	0.00608	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000199	0.00594	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—GPX3—uterine cancer	0.000199	0.00594	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000196	0.00583	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—IRF1—uterine cancer	0.00019	0.00568	CbGpPWpGaD
Chlorzoxazone—Dizziness—Epirubicin—uterine cancer	0.000187	0.00362	CcSEcCtD
Chlorzoxazone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000179	0.00534	CbGpPWpGaD
Chlorzoxazone—Rash—Epirubicin—uterine cancer	0.000179	0.00345	CcSEcCtD
Chlorzoxazone—Dermatitis—Epirubicin—uterine cancer	0.000178	0.00344	CcSEcCtD
Chlorzoxazone—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000178	0.0053	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000177	0.00527	CbGpPWpGaD
Chlorzoxazone—Dizziness—Doxorubicin—uterine cancer	0.000173	0.00335	CcSEcCtD
Chlorzoxazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000171	0.00511	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000171	0.00509	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000167	0.00499	CbGpPWpGaD
Chlorzoxazone—Rash—Doxorubicin—uterine cancer	0.000165	0.00319	CcSEcCtD
Chlorzoxazone—Dermatitis—Doxorubicin—uterine cancer	0.000165	0.00319	CcSEcCtD
Chlorzoxazone—CYP1A2—Tryptophan metabolism—CYP19A1—uterine cancer	0.000163	0.00486	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Biological oxidations—CYP11A1—uterine cancer	0.000162	0.00484	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—AKR1B10—uterine cancer	0.000161	0.00481	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000156	0.00464	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000155	0.00463	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000153	0.00457	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—AKR1B1—uterine cancer	0.00015	0.00447	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000146	0.00436	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000145	0.00433	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000138	0.00412	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	0.000137	0.00408	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000136	0.00407	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—GPX3—uterine cancer	0.000136	0.00406	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000132	0.00393	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—PTEN—uterine cancer	0.000131	0.00389	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.00013	0.00388	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—GPX3—uterine cancer	0.000128	0.00383	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—CYP11A1—uterine cancer	0.000128	0.00382	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Fluoropyrimidine Activity—TP53—uterine cancer	0.000128	0.0038	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	0.000127	0.00379	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000127	0.00377	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000126	0.00376	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000126	0.00375	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—EP300—uterine cancer	0.000124	0.00371	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—CYP11A1—uterine cancer	0.000121	0.0036	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000119	0.00356	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Biological oxidations—CYP19A1—uterine cancer	0.000119	0.00356	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000119	0.00356	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000116	0.00346	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	0.000116	0.00346	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000113	0.00336	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000112	0.00334	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	0.00011	0.00328	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000109	0.00324	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000107	0.0032	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000107	0.00318	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000106	0.00315	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.000102	0.00304	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	0.000102	0.00304	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000102	0.00303	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.0001	0.00299	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	9.81e-05	0.00292	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	9.67e-05	0.00288	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	9.65e-05	0.00288	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	9.53e-05	0.00284	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	9.44e-05	0.00281	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	9.33e-05	0.00278	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	9.31e-05	0.00277	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	9.1e-05	0.00271	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	8.98e-05	0.00268	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—TP53—uterine cancer	8.91e-05	0.00266	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—CYP19A1—uterine cancer	8.9e-05	0.00265	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—CYP19A1—uterine cancer	8.78e-05	0.00262	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	8.48e-05	0.00253	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	8.24e-05	0.00246	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	8.2e-05	0.00245	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	8.19e-05	0.00244	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.76e-05	0.00231	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.76e-05	0.00231	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	7.71e-05	0.0023	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	7.6e-05	0.00227	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	7.4e-05	0.00221	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	7.4e-05	0.00221	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	7.2e-05	0.00215	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	7.18e-05	0.00214	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	6.97e-05	0.00208	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	6.84e-05	0.00204	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	6.7e-05	0.002	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	6.6e-05	0.00197	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Neuronal System—HRAS—uterine cancer	6.55e-05	0.00195	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	6.5e-05	0.00194	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	6.5e-05	0.00194	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—NDUFB11—uterine cancer	6.42e-05	0.00191	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—SRD5A2—uterine cancer	6.42e-05	0.00191	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	6.32e-05	0.00188	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	6.15e-05	0.00183	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	6.08e-05	0.00181	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	5.95e-05	0.00177	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—EP300—uterine cancer	5.95e-05	0.00177	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	5.87e-05	0.00175	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.7e-05	0.0017	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	5.67e-05	0.00169	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—VEGFA—uterine cancer	5.63e-05	0.00168	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	5.6e-05	0.00167	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—NRAS—uterine cancer	5.56e-05	0.00166	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	5.54e-05	0.00165	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	5.23e-05	0.00156	CbGpPWpGaD
Chlorzoxazone—CYP1A1—PPARA activates gene expression—EP300—uterine cancer	5.07e-05	0.00151	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—SRD5A2—uterine cancer	5.07e-05	0.00151	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NDUFB11—uterine cancer	5.07e-05	0.00151	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	4.96e-05	0.00148	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.95e-05	0.00148	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.95e-05	0.00148	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—KRAS—uterine cancer	4.79e-05	0.00143	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NDUFB11—uterine cancer	4.78e-05	0.00143	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—SRD5A2—uterine cancer	4.78e-05	0.00143	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.64e-05	0.00138	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—AKR1B1—uterine cancer	4.64e-05	0.00138	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—STAR—uterine cancer	4.64e-05	0.00138	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	4.45e-05	0.00133	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—PIK3CA—uterine cancer	4.4e-05	0.00131	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.39e-05	0.00131	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	4.38e-05	0.00131	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	4.32e-05	0.00129	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—TP53—uterine cancer	4.26e-05	0.00127	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—HRAS—uterine cancer	4.07e-05	0.00121	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—AKR1B1—uterine cancer	3.67e-05	0.00109	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—STAR—uterine cancer	3.67e-05	0.00109	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—POLD1—uterine cancer	3.64e-05	0.00109	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.63e-05	0.00108	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NDUFB11—uterine cancer	3.6e-05	0.00107	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SRD5A2—uterine cancer	3.6e-05	0.00107	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—AKT1—uterine cancer	3.59e-05	0.00107	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—STAR—uterine cancer	3.46e-05	0.00103	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—AKR1B1—uterine cancer	3.46e-05	0.00103	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	3.42e-05	0.00102	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.42e-05	0.00102	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—AKR1C1—uterine cancer	3.41e-05	0.00101	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SRD5A2—uterine cancer	3.05e-05	0.000909	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NDUFB11—uterine cancer	3.05e-05	0.000909	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—RRM2—uterine cancer	3.03e-05	0.000905	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.96e-05	0.000883	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—DCN—uterine cancer	2.95e-05	0.000878	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—POLD1—uterine cancer	2.88e-05	0.000857	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.8e-05	0.000833	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYP11A1—uterine cancer	2.78e-05	0.000827	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—POLD1—uterine cancer	2.71e-05	0.000808	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—AKR1C1—uterine cancer	2.69e-05	0.000802	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—AKR1C3—uterine cancer	2.62e-05	0.000781	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—AKR1B1—uterine cancer	2.6e-05	0.000775	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—STAR—uterine cancer	2.6e-05	0.000775	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—AKR1C1—uterine cancer	2.54e-05	0.000756	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—RRM2—uterine cancer	2.4e-05	0.000715	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.35e-05	0.000701	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.35e-05	0.000701	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—DCN—uterine cancer	2.33e-05	0.000694	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—RRM2—uterine cancer	2.26e-05	0.000674	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—STAR—uterine cancer	2.2e-05	0.000657	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—AKR1B1—uterine cancer	2.2e-05	0.000657	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—DCN—uterine cancer	2.2e-05	0.000654	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP11A1—uterine cancer	2.19e-05	0.000654	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.18e-05	0.000649	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—AKR1C3—uterine cancer	2.07e-05	0.000617	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP11A1—uterine cancer	2.07e-05	0.000616	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—STK11—uterine cancer	2.04e-05	0.000609	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYP19A1—uterine cancer	2.04e-05	0.000609	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—POLD1—uterine cancer	2.04e-05	0.000608	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—AKR1C3—uterine cancer	1.95e-05	0.000582	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.91e-05	0.000569	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—POLD1—uterine cancer	1.73e-05	0.000515	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—RRM2—uterine cancer	1.7e-05	0.000507	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.7e-05	0.000507	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—STAR—uterine cancer	1.7e-05	0.000507	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—DCN—uterine cancer	1.65e-05	0.000492	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.62e-05	0.000482	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—STK11—uterine cancer	1.61e-05	0.000481	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP19A1—uterine cancer	1.61e-05	0.000481	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.56e-05	0.000464	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—MTHFR—uterine cancer	1.53e-05	0.000457	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—STK11—uterine cancer	1.52e-05	0.000454	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP19A1—uterine cancer	1.52e-05	0.000454	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.47e-05	0.000438	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—RRM2—uterine cancer	1.44e-05	0.00043	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.43e-05	0.000426	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—DCN—uterine cancer	1.4e-05	0.000417	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.36e-05	0.000406	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—POLD1—uterine cancer	1.33e-05	0.000398	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.32e-05	0.000393	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.25e-05	0.000372	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.25e-05	0.000371	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—MTHFR—uterine cancer	1.21e-05	0.000361	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—STK11—uterine cancer	1.15e-05	0.000341	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.15e-05	0.000341	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—MTHFR—uterine cancer	1.14e-05	0.000341	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—RRM2—uterine cancer	1.11e-05	0.000332	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—DCN—uterine cancer	1.08e-05	0.000322	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.02e-05	0.000303	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.01e-05	0.0003	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—STK11—uterine cancer	9.7e-06	0.000289	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP19A1—uterine cancer	9.7e-06	0.000289	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—AKR1C3—uterine cancer	9.61e-06	0.000286	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.11e-06	0.000271	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.69e-06	0.000259	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—MTHFR—uterine cancer	8.61e-06	0.000257	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PTEN—uterine cancer	8.54e-06	0.000254	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—EP300—uterine cancer	8.14e-06	0.000243	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—STK11—uterine cancer	7.49e-06	0.000223	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP19A1—uterine cancer	7.49e-06	0.000223	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MTHFR—uterine cancer	7.29e-06	0.000217	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PTEN—uterine cancer	6.75e-06	0.000201	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—EP300—uterine cancer	6.43e-06	0.000192	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.42e-06	0.000191	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PTEN—uterine cancer	6.36e-06	0.00019	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—EP300—uterine cancer	6.07e-06	0.000181	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PIK3CA—uterine cancer	6.02e-06	0.00018	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MTHFR—uterine cancer	5.63e-06	0.000168	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—AKT1—uterine cancer	4.92e-06	0.000147	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PTEN—uterine cancer	4.79e-06	0.000143	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PIK3CA—uterine cancer	4.76e-06	0.000142	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—EP300—uterine cancer	4.57e-06	0.000136	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PIK3CA—uterine cancer	4.49e-06	0.000134	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PTEN—uterine cancer	4.06e-06	0.000121	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—AKT1—uterine cancer	3.89e-06	0.000116	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—EP300—uterine cancer	3.87e-06	0.000115	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—AKT1—uterine cancer	3.67e-06	0.000109	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PIK3CA—uterine cancer	3.38e-06	0.000101	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PTEN—uterine cancer	3.13e-06	9.33e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—EP300—uterine cancer	2.99e-06	8.9e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.86e-06	8.53e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—AKT1—uterine cancer	2.76e-06	8.22e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—AKT1—uterine cancer	2.34e-06	6.97e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.21e-06	6.58e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—AKT1—uterine cancer	1.8e-06	5.38e-05	CbGpPWpGaD
